NASDAQ:FUSN
Fusion Pharmaceuticals Inc.
- Stock
Last Close
21.52
03/06 20:00
Market Cap
1.83B
Beta: −1.15
Volume Today
6.08M
Avg: 377.71K
PE Ratio
−8.03
PFCF: −8.88
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 669K - | 2.37M 254.78% | 7.31M 208.01% | 254K 96.53% | -4.93M 2,042.72% | |||
average payables | 589.50K - | 2.11M 258.69% | 2.80M 32.28% | 2.44M 12.75% | 2.27M 6.86% | |||
average receivables | 455.50K - | 611K 34.14% | 575.50K 5.81% | 1.04M 80.71% | 865K 16.83% | |||
book value per share | -0.96 - | -1.57 64.03% | 13.37 950.32% | 5.43 59.35% | 3.71 31.75% | 0.00 99.91% | ||
capex per share | -0.01 - | -0.06 1,069.79% | -0.02 64.36% | -0.05 138.11% | -0.04 31.33% | -0.05 39.89% | -0.00 99.88% | |
capex to depreciation | -4.17 - | -9.85 136.01% | -1.57 84.04% | -2.33 48.17% | -2.35 0.94% | -2.36 0.20% | -2.89 22.74% | |
capex to operating cash flow | 0.02 - | 0.11 626.23% | 0.03 70.74% | 0.04 13.26% | 0.02 47.82% | 0.03 48.49% | 0.05 62.68% | |
capex to revenue | -1.04 - | -1.47 41.60% | -1.88 28.30% | |||||
cash per share | 1.54 - | 3.07 99.34% | 10.09 229.08% | 4.71 53.30% | 3.91 17.14% | 0.00 99.91% | ||
days of inventory on hand | ||||||||
days payables outstanding | ||||||||
days sales outstanding | 90.49 - | 430.46 375.70% | 1.24 99.71% | |||||
debt to assets | 0.03 - | 0.18 589.60% | 0.18 4.17% | |||||
debt to equity | 0.03 - | 0.25 754.40% | 0.23 8.83% | |||||
dividend yield | 0.01 - | |||||||
earnings yield | -0.02 - | -0.04 86.02% | -0.04 21.93% | -0.30 576.87% | -0.46 50.79% | -0.64 39.34% | -0.00 99.98% | |
enterprise value | 289.06M - | 296.81M 2.68% | 168.37M 43.27% | 131.46M 21.92% | 134.20M 2.08% | 630.52B 469,735.91% | ||
enterprise value over ebitda | -29.95 - | -16.72 44.19% | -5.42 67.57% | -1.62 70.21% | -1.53 5.22% | -6.35K 414,888.89% | ||
ev to operating cash flow | -29.30 - | -21.68 26.00% | -5.66 73.91% | -1.74 69.31% | -1.83 5.52% | -7.71K 420,766.19% | ||
ev to sales | 91.29 - | 91.85 0.62% | 304.89K 331,829.53% | |||||
free cash flow per share | -0.33 - | -0.59 76.64% | -0.66 12.97% | -1.40 111.13% | -1.81 29.32% | -1.72 4.91% | -0.00 99.92% | |
free cash flow yield | -0.02 - | -0.03 76.64% | -0.04 12.97% | -0.12 205.47% | -0.43 264.38% | -0.55 25.88% | -0.00 99.98% | |
graham net net | -1.06 - | -1.74 64.20% | 9.48 646.45% | 4.35 54.10% | 2.52 42.04% | 0.00 99.90% | ||
graham number | 3.67 - | 5.18 41.42% | 32.70 530.72% | 15.25 53.36% | 12.93 15.24% | 0.01 99.92% | ||
income quality | 0.98 - | 0.85 13.41% | 0.85 0.13% | 0.38 55.06% | 0.93 145.92% | 0.84 10.50% | 0.86 3.07% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -116.01 - | -48.88 - | 19.21 139.30% | |||||
interest debt per share | 0.01 - | 0.16 963.24% | 0.96 509.18% | 0.00 99.93% | ||||
inventory turnover | ||||||||
invested capital | 0.03 - | 0.25 754.40% | 0.23 8.83% | |||||
market cap | 317.83M - | 317.83M 0% | 362.16M 13.95% | 258.89M 28.51% | 177.64M 31.39% | 137.81M 22.42% | 630.53B 457,443.03% | |
net current asset value | -19.07M - | -36.34M 90.51% | 212.00M 683.46% | 190.95M 9.93% | 122.16M 36.03% | 180.04M 47.39% | ||
net debt to ebitda | 2.98 - | 3.68 23.46% | 2.91 20.80% | 0.57 80.53% | 0.04 92.75% | 0.11 172.35% | ||
net income per share | -0.34 - | -0.62 86.02% | -0.76 21.93% | -3.56 367.84% | -1.90 46.49% | -2.00 5.26% | -0.00 99.93% | |
operating cash flow per share | -0.33 - | -0.53 61.08% | -0.64 21.78% | -1.35 110.23% | -1.78 31.60% | -1.67 5.80% | -0.00 99.93% | |
payables turnover | ||||||||
receivables turnover | 4.03 - | 0.85 78.98% | 295.43 34,740.75% | |||||
research and ddevelopement to revenue | 39.14 - | 40.31 3.00% | 33.90 15.91% | |||||
return on tangible assets | -0.37 - | -0.23 37.16% | -0.25 8.09% | -0.32 27.42% | -0.40 24.49% | -0.33 16.99% | ||
revenue per share | 0.03 - | 0.03 1.21% | 0.00 99.91% | |||||
roe | 0.65 - | 0.48 25.66% | -0.27 155.02% | -0.35 31.65% | -0.54 54.24% | -0.43 21.02% | ||
roic | 0.57 - | 0.55 3.48% | -0.13 124.11% | -0.33 150.97% | -0.41 23.67% | -0.34 17.49% | ||
sales general and administrative to revenue | 18.82 - | 20.94 11.30% | 15.09 27.97% | |||||
shareholders equity per share | -0.96 - | -1.57 64.03% | 13.37 950.32% | 5.43 59.35% | 3.71 31.75% | 0.00 99.91% | ||
stock based compensation to revenue | 5.97 - | 7.42 24.24% | 6.02 18.93% | |||||
tangible asset value | -17.92M - | -33.49M 86.91% | 294.51M 979.46% | 231.46M 21.41% | 162.22M 29.91% | 222.48M 37.15% | ||
tangible book value per share | -0.96 - | -1.57 64.03% | 13.37 950.32% | 5.43 59.35% | 3.71 31.75% | 0.00 99.91% | ||
working capital | 28.64M - | 62.28M 117.48% | 216.31M 247.31% | 199.25M 7.89% | 163.93M 17.73% | 227.18M 38.58% |
All numbers in USD (except ratios and percentages)